Deal Announcements

Axikin Garners $3 Million Venture Capital Funding

Friday, January 23, 2009 5:38:00 AM PDT | VentureDeal Staff

San Diego, California  --  Stealth mode of pharmaceutical company Axikin Pharmaceuticals (no website) has secured $3 million in its series A round of venture capital investment.

Axikin is a very early stage pharmaceutical company that is developing as-yet unspecified drugs and treatments.

Sanderling Ventures was the lead investor in the round, which also included Mitsui & Co. Venture Partners. Proceeds purposes from the financing were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1